content

ADCs Built On Starpharma Delivery Tech To Be Tested By Merck

As it works to expand its antibody-drug conjugate (ADC) capabilities, Merck has strengthened its links to Starpharma by signing a second partnership that will...

After Roe, Bayer Engages Lobbyists For Contraception Access

While a large portion of the biopharma industry prepares for a battle over medication prices, Bayer is getting ready for a different lobbying push...

Trodelvy Wins A Battle Against Breast Cancer With Gilead

Gilead staked money on Trodelvy providing a life-extension benefit when it failed to show promise in halting tumour development in HR-positive HER2-negative breast cancer....

Study Uncovers And Exploits Flaws In Some High-Risk Cancers

A team of researchers led by C. Patrick Reynolds, M.D., Ph.D., director of the Texas Tech University Health Sciences Center (TTUHSC) School of Medicine...

Nasal Administration Could Boost HIV And COVID-19 Vaccines

A team led by an assistant professor from the University of Minnesota in the USย has created a new method to successfully administer vaccines through...

Enhertu From AZ, Daiichi Sankyo Now Has The FDA Approval

With two significant FDA clearances in as many weeks, Enhertu from AstraZeneca and Daiichi Sankyo is blazing. On August 11th, the medication obtained rapid approval...

Pfizer Provides Evidence To Back The Clearance Of Prevnar 20

Although Pfizer beat Merck to sell its next-generation pneumococcal vaccination, it lost a more important battle in June when the FDA said its competitor...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read